ARTICLE | Clinical News
FDA approves Biocodex's Diacomit for Dravet syndrome seizures
August 31, 2018 5:59 PM UTC
FDA approved Diacomit stiripentol from Laboratoires Biocodex (Gentilly, France) to treat seizures associated with Dravet syndrome in patients ages two and older who are taking clobazam. The anticonvu...
BCIQ Company Profiles
BCIQ Target Profiles